Phase 1 Trial: Promising Results in Cancer Treatment
Phase 1 clinical trials represent a critical juncture in the development of new cancer therapies. These trials are primarily designed to assess the safety, tolerability, and pharmacokinetics of a new treatment in a small group of participants, typically ranging from 20 to 100 individuals. In the context of oncology, Phase 1 trials often involve patients […]
Phase 1 Trial: Promising Results in Cancer Treatment Read More »










